Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Avalanche Biotechnologies Inc announces closing of initial public offering and exercise of underwriters' option to purchase additional shares


Tuesday, 5 Aug 2014 04:05pm EDT 

Avalanche Biotechnologies Inc:Closes initial public offering of 6,900,000 shares of its common stock at a public offering price of $17.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 900,000 additional shares of common stock.All of the shares of common stock were offered by Avalanche.Estimates net proceeds from the offering to be about $106.8 mln, after deducting underwriting discounts and commissions and estimated offering expenses.Jefferies LLC, Cowen and Company, LLC and Piper Jaffray & Co. acted as joint book-running managers and William Blair & Company, L.L.C. acted as co-manager for the offering.